1. Articles in category: Other Business News

    1153-1176 of 1180 « 1 2 ... 46 47 48 49 50 »
    1. Michelson Diagnostics Announces Development of In-Vivo OCT Probes

      Press Release: For immediate release 17 March 2008 Michelson Diagnostics Announces Development of In-Vivo OCT probes (177 Words) Cancer imaging technology company Michelson Diagnostics Ltd (MDL) has announced that it has commenced the engineering phase of its development of probes for in-vivo imaging with optical coherence tomography (OCT). According to MDL Applications Director Dr Gordon McKenzie, more than one type of probe will start clinical testing during 2008. The probes will be suitabl
      Read Full Article
    2. WiOptix, Inc. Medical Imaging Technology

      WiOptix, Inc. Medical Imaging Technology
      WiOptix, Inc. (WOI) is a company focused on producing highly accurate and low cost systems for early cancer diagnosis and imaging-guided surgery. Our technique uses light to examine cells/tissues in vivo for abnormalities without relying on a surgical biopsy. The WOI systems generate real-time, cellular-level, 3-D images using small optical probes (less than 5mm in diameter). This major improvement in optical imaging is based on the proprietary technology developed at the University of Florida’s Biophotonics & Microsystems Lab under the leadership of Dr. Huikai Xie.
      Read Full Article
    3. Optovue Fastest Growing Ophthalmic Device Company in Eye Care

      Fremont, CA - January 19, 2008 - Optovue, Inc., the first company to introduce a Fourier-domain optical coherence tomography (FD-OCT) system to the US market, today announced it achieved its 2007 unit sales, revenue and profitability goals, making it one of the fastest growing companies in eye care history. In their first full year of sales to the eye care market, Optovue announced that it installed 425 of the RTVue FD-OCT systems. Twenty five of the units were placed in clinical sites for data
      Read Full Article
    4. Ophthalmic OCT CPT 92135 Reimbursement Guide

      Ophthalmic OCT CPT 92135 Reimbursement Guide
      This reimbursement guide addresses specifically the Medicare reimbursement and documentation requirements for billing ocular coherence tomography (OCT) as it relates to the Spectralis. Providers should note that appropriate ICD-9-CM diagnosis codes are required to substantiate medical necessity when billing these services. As with any service billed to Medicare, providers are encouraged to check with their local Medicare carrier for specific billing and documentation guidelines.
      Read Full Article
    5. OCT market set for rapid growth

      The optical coherence tomography (OCT) market looks poised for continued growth, with revenues expected to top $800 million by 2012. That's the conclusion of a new market research report, Optical Coherence Tomography - Technology, Markets and Applications: 2008-2012. The report, published by US media company PennWell (Tulsa, OK), estimates that the global market for OCT systems currently stands at around $200 million and is growing at an annual rate of 34%. OCT is a non-invasive optical imaging
      Read Full Article
    6. Optical Coherence Tomography Market To Top $800 Million By 2012

      According to "Optical Coherence Tomography -- Technology, Markets, and Applications: 2008-2012," a new market research report from the publishers of BioOptics World that quantifies this rapidly growing market for the first time, the global market for OCT systems is currently around $200 million and growing at an annual rate of 34%. This growth is expected to continue at this pace for the next several years, with revenues topping $800 million by 2012.
      Read Full Article
    7. John Moore Appointed to Staar Surgical Board Of Directors

      Ophthalmic Medical Device Industry Veteran Joins STAAR Board MONROVIA, Calif., Jan. 14 (HSMN NewsFeed) -- STAAR Surgical Company (Nasdaq: STAA ), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced... Devices, Ophthalmology, PersonnelSTAAR Surgical
      Read Full Article
    8. Still evolving, OCT technology has revolutionized diagnostics

      Still evolving, OCT technology has revolutionized diagnostics
      Since the early 1990s, optical coherence tomography has revolutionized the way retinal and glaucoma surgeons approach diagnostics in their practices, and it continues to show promise for additional applications. When the technology for optical coherence tomography (OCT) was first developed in 1991, surgeons were impressed by the precise imaging created by this modality but questioned if it would become clinically indispensable. Now, many cannot imagine their practices without it. “At first I was
      Read Full Article
    9. Carl Zeiss Meditec OCT News

      Spectral Domain of the product The main benefit — A Revolutionary New Technology Carl Zeiss Meditec unveils new Cirrus HD-OCT system, the newest member of their Retinal Imaging Adio diam nonse tis eugait ver ipiscin iamcon Family. Carl Zeiss Meditec unveiled Cirrus HDOCT, its new high iamconsequip etue Adio diam nonse tis eugait ver ipiscin definition spectral domain retinal deliquamet at the doluptat augiam alisissed dio el iritOCT system, adipisi November 2006 dolor
      Read Full Article
    10. Optovue Receives FDA Clearance for Cornea/Anterior Module for RTVue

      Fremont, CA — October 25, 2007 - Optovue, Inc., the first company to introduce a Fourier-domain optical coherence tomography (FD-OCT) system to the US market, today announced that on September 28, FDA 510(k) clearance was received for its Cornea/Anterior Module (CAM). The CAM is an optional attachment for the RTVue, Optovue’s high-speed and high-resolution FD-OCT device for retinal imaging. The CAM add-on enhances the RTVue by enabling five-micron resolution, high-magnification imaging of the co
      Read Full Article
    11. Lantis Laser Update: CEO Reports Market Introduction On Track for '08

      DENVILLE, N.J., Nov. 20, 2007 (PRIME NEWSWIRE) -- Lantis Laser Inc. (Pink Sheets:LLSR) (http://www.lantislaser.com) is reporting its corporate developments are on track for next year. Company CEO Stan Baron provided shareholders with a report card concerning progress with OCT developments including timing for full market rollout as well as plans for moving the stock from the Pink Sheets to other exchanges. Mr. Baron commented, "Since the last round of funding was completed in the middle of May w
      Read Full Article
    12. Carl Zeiss Meditec Sues, Seeks Protection of Proprietary Information

      Carl Zeiss Meditec (CZMI) announced it recently filed a lawsuit against a former senior sales executive who is now employed by the company’s direct competitor, Optovue. The company filed the suit June 7 in Massachusetts, alleging that the executive, while employed by CZMI, transmitted confidential and proprietary company information to Optovue and engaged in a variety of prohibited actions during and subsequent to his CZMI empl
      Read Full Article
    13. Tomophase to Exhibit First Cross-Sectional Images of Human Bronchus Using Proprietary OCT System

      【字体:大 中 小】 】   BURLINGTON, Mass., Oct. 17 /PRNewswire/ -- Tomophase Corporation announced today that it will display the first cross-sectional images of excised human bronchial tissue using their patented optical coherence tomography ("OCT") system at the CHEST meeting in Chicago, October 22nd through October 24th. The images were captured using the Tomophase OCT system as part of an ongoing research collaboration with Dr. Armin Ernst, Director of Interventional Pulmonology, at Be
      Read Full Article
    1153-1176 of 1180 « 1 2 ... 46 47 48 49 50 »
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. Popular Articles

  3. OCT Companies in the News

    1. (1 articles) Avinger
    2. (1 articles) Carl Zeiss Meditec